Company search
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Data as at: 12/02/2026
In
Objective
To achieve long-term capital growth by investing in biotechnology and other life sciences companies.
AIC sector
Management group
Company website
Launch date
06/05/1994
August
Domicile
United Kingdom
Fund manager
Ailsa Craig, Marek Poszepczynski
Dividend frequency
Semi-Annually
Wind-up provisions
The Association Articles of the company provide for Directors to put forward a proposal for the continuation of the company at the AGM at two-yearly intervals. The upcoming continuation vote is scheduled for the December 2025 AGM.
Continuation vote
2 yearly
| Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
|---|---|---|---|---|---|---|---|---|
| 282.02 | 336.10 | 884.00 | 970.03 | -8.87 | 9 | 3.59 | Jul, Dec | 1.3 (31/08/2025) |
Scroll
Dividends
Dividends declared in last 12 months
| Ex-dividend date | Payment date | Dividend amount | Special dividend | Financial year |
|---|---|---|---|---|
| 29/12/2025 | 23/01/2026 | 15.640 | No | 2026 |
| 24/07/2025 | 22/08/2025 | 16.170 | No | 2025 |
Scroll
Performance (%)
| Return type | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| International Biotechnology | Share price total return | 29.7 | 39.7 | 29.1 | 237.4 |
| Biotechnology & Healthcare AIC sector | Share price total return | 15.1 | 2.2 | -19.3 | 109.3 |
Scroll
Share structure
Number of shares
31,902,834
9,480,983
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 186,707 | 1,764,963 | 26,593,569 | 90,190,913 |
| Average | N/A | 76,738 | 105,113 | 71,523 |
Scroll
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 1.65 | 16.55 | 196.64 | 630.46 |
| Average | N/A | 0.72 | 0.78 | 0.50 |
Scroll
Trading details
| ISIN | Ticker | Traded currency | Stock exchange |
|---|---|---|---|
| GB0004559349 | IBT | GBX | London Stock Exchange - MAIN Chi-x Europe Limited London Stock Exchange |
Scroll
Top holdings
Data as at : 30/09/2025
| Investment | % of total assets |
|---|---|
| Vera Therapeutics Inc Class A | 5.6 |
| Soleno Therapeutics Inc | 5.4 |
| KalVista Pharmaceuticals Inc | 4.0 |
| Avidity Biosciences Inc Ordinary Shares | 3.9 |
| Amgen Inc | 3.6 |
| Sv Bcof | 3.6 |
| Sv Fund Vi Investment | 3.2 |
| Autolus Therapeutics PLC ADR | 3.1 |
| Cytokinetics Inc | 2.9 |
| Scb Sholo211123b 22-May-2025 5.41% 23-Jun-2025 | -5.7 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
